These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 7564273)

  • 1. Reduced expression of platelet surface glycoprotein receptor IIb/IIIa at hyperthermic temperatures.
    Pasha R; Benavides M; Kottke-Marchant K; Harasaki H
    Lab Invest; 1995 Sep; 73(3):403-8. PubMed ID: 7564273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
    Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA
    Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
    Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
    Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High shear stress attenuates agonist-induced, glycoprotein IIb/IIIa-mediated platelet aggregation when von Willebrand factor binding to glycoprotein Ib/IX is blocked.
    Iijima K; Murata M; Nakamura K; Kitaguchi T; Handa M; Watanabe K; Fujimura Y; Yoshioka A; Ikeda Y
    Biochem Biophys Res Commun; 1997 Apr; 233(3):796-800. PubMed ID: 9168936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
    Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD
    Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycoprotein IIb-IIIa content and platelet aggregation in healthy volunteers and patients with acute coronary syndrome.
    Yakushkin VV; Zyuryaev IT; Khaspekova SG; Sirotkina OV; Ruda MY; Mazurov AV
    Platelets; 2011; 22(4):243-51. PubMed ID: 21329420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic redistribution of major platelet surface receptors after contact-induced platelet activation and spreading. An immunoelectron microscopy study.
    Kieffer N; Guichard J; Breton-Gorius J
    Am J Pathol; 1992 Jan; 140(1):57-73. PubMed ID: 1309961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences between platelet and microparticle glycoprotein IIb/IIIa.
    Nomura S; Suzuki M; Kido H; Yamaguchi K; Fukuroi T; Yanabu M; Soga T; Nagata H; Kokawa T; Yasunaga K
    Cytometry; 1992; 13(6):621-9. PubMed ID: 1451594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-glycoprotein Ib causes platelet aggregation: different effects of blocking glycoprotein Ib and glycoprotein IIb/IIIa in the high shear filterometer.
    O'Brien JR; Etherington MD
    Blood Coagul Fibrinolysis; 1998 Sep; 9(6):453-61. PubMed ID: 9818994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of human platelet IgG Fc receptor associated with membrane glycoprotein.
    Shido K; Ahmad G; Hsu L; Kamiyama M
    J Clin Lab Immunol; 1995; 46(1):1-11. PubMed ID: 9363587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro.
    Matzdorff AC; Kühnel G; Kemkes-Matthes B; Pralle H; Voss R; Fareed J
    J Lab Clin Med; 2000 Mar; 135(3):247-55. PubMed ID: 10711863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding.
    Kleinschnitz C; Pozgajova M; Pham M; Bendszus M; Nieswandt B; Stoll G
    Circulation; 2007 May; 115(17):2323-30. PubMed ID: 17438148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A defined peptide that inhibits the formation of the glycoprotein IIb and IIIa complex.
    Chiang TM; Zhu J
    Thromb Res; 2005; 115(6):503-8. PubMed ID: 15792682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ca+2 mobilization and fibrinogen binding of platelets refractory to adenosine diphosphate stimulation.
    Peerschke EI
    J Lab Clin Med; 1985 Aug; 106(2):111-22. PubMed ID: 2991399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of platelet glycoprotein IIb-IIIa number and glycoprotein IIIa Leu33Pro polymorphism on platelet aggregation and sensitivity to glycoprotein IIb-IIIa antagonists.
    Sirotkina OV; Khaspekova SG; Zabotina AM; Shimanova YV; Mazurov AV
    Platelets; 2007 Nov; 18(7):506-14. PubMed ID: 17957566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clues for understanding the structure and function of a prototypic human integrin: the platelet glycoprotein IIb/IIIa complex.
    Calvete JJ
    Thromb Haemost; 1994 Jul; 72(1):1-15. PubMed ID: 7974356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shear stress-induced binding of von Willebrand factor to platelets.
    Konstantopoulos K; Chow TW; Turner NA; Hellums JD; Moake JL
    Biorheology; 1997; 34(1):57-71. PubMed ID: 9176590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined defect in membrane expression and activation of platelet GPIIb--IIIa complex without primary sequence abnormalities in myeloproliferative disease.
    Kaplan R; Gabbeta J; Sun L; Mao GF; Rao AK
    Br J Haematol; 2000 Dec; 111(3):954-64. PubMed ID: 11122160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated fibrinogen fragment levels in uremic plasma inhibit platelet function and expression of glycoprotein IIb-IIIa.
    Thekkedath UR; Chirananthavat T; Leypoldt JK; Cheung AK; Mohammad SF
    Am J Hematol; 2006 Dec; 81(12):915-26. PubMed ID: 16917914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of PM6/13, a beta3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets.
    Patel Y; Rahman S; Siddiqua A; Wilkinson JM; Kakkar VV; Authi KS
    Thromb Haemost; 1998 Jan; 79(1):177-85. PubMed ID: 9459345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.